Fundamental Research Analysts Give Lexaria Bioscience (LXX) a $3.50 Price Target

Share on StockTwits

Lexaria Bioscience (CNSX:LXX) has been given a $3.50 price objective by Fundamental Research in a research note issued on Wednesday. The brokerage currently has a “buy” rating on the stock. Fundamental Research’s target price suggests a potential upside of 116.05% from the stock’s current price.

The analysts wrote, “Fundamental Research Corp has issued a report entitled “Lexaria Bioscience Corp. (OTCQX: LXRP; CSE: LXX) – Additional Licensees and Expanded Intellectual Property Portfolio” and dated August 29, 2018. The full report is now at www.researchfrc.com.

Join us September 19-20 at the Extraordinary Future Conference to explore Canada’s hottest tech investment opportunities!

 Gain early access to new projects and recommendations from world-class speakers

 Connect with over 50 innovative tech companies on the tradeshow floor

 Mingle with industry influencers and ultra-successful investors

 Take advantage of one-on-one meeting opportunities in the Deal Room

Find out more and register with promo code FRCGUEST for 50% off your two-day pass:

http://cambridgehouse.com/e/extraordinary-future-2018-74?utm_medium=banner&utm_source=FRC&utm_campaign=xfuture18&utm_term=-&utm_content=register-for-xfuture2018

The #1 meeting place for the entire mining investment community – Canada, US, Latin America

Toronto, October 15-17

Mines and Money – the leading international event series for capital raising and mining investment – returns to Toronto this October, bringing together miners, investors and financiers.

• Top investor and analyst keynotes on Gold, Silver, Battery metals and more

• Geo focussed agenda targeting the key topics from the US, Canada and Latin America

• Hands-on exhibition area showcasing the leading miners, providers and tech

• Personalised investor relations service matching miners with the best investors

Don’t miss out on the region’s leading mining investment show – click here for more information:

https://americas.minesandmoney.com/?utm_source=Media%20Partner&utm_medium=Listing&utm_campaign=MMA&utm_content=Fundamental%20Research%20Corp

Speak to the experts, meet with the companies, make valuable decisions: Join us at the Silver & Gold Summit October 28-29!

The Silver and Gold Summit facilitates discussions and debates on precious metals trends, geopolitical risk and investment opportunities within the natural resource economy

2018 Topics will include:

• Emerging Mid-Tiers

• Drill Hole Glory

• Silver Producers

• Battery Metals

• Uranium Energy

• Silver in Healthcare

Put your money to work with over 70 leading investment opportunities!

Find out more and register with promo code FRCGUEST for 50% off your two-day pass: https://goo.gl/y5AsY9

Shares of CNSX LXX traded down $0.12 during midday trading on Wednesday, hitting $1.62. 184,580 shares of the company’s stock were exchanged, compared to its average volume of 250,001. Lexaria Bioscience has a twelve month low of $0.27 and a twelve month high of $2.54.

Recommended Story: How Do You Calculate Return on Investment (ROI)?

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply